SCHEMBL22944898

SCHEMBL22944898

CCCC1(CNC)CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 19/20 0.37
SLC6A3 Q01959 18/20 0.35
SLC6A2 P23975 8/20 0.35
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17662686 0.93 SLC6A4 (0.31) SLC6A4SLC6A3
SCHEMBL22944895 0.81 SLC6A4 (0.39) SLC6A4SLC6A3SLC6A2
SCHEMBL17662599 0.80 EPHX1 (0.31)
SCHEMBL202959 0.80 USP2 (0.31) LMNA
SCHEMBL487371 0.80 USP2 (0.31) LMNA
SCHEMBL20170950 0.78 KDM4E (0.31)
SCHEMBL25819859 0.78 SLC6A4 (0.36) SLC6A4SLC6A3SLC6A2
SCHEMBL487300 0.77
SCHEMBL13849274 0.77
SCHEMBL8015433 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021979-A2 HDAC6 INHIBITORS AND USES THEREOF EIKONIZO THERAPAPEUTICS, INC. (US) 2021-02-04 WO disclosed